Clinical TrialsSearch results
Number of results: 2568
Completed
- A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors
- Solid Tumors
- Tanigawa Takahiko
- 2021-03-10
Completed
- A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.
- Respiratory Tract Infection
- Kawai Norisuke
- 2020-10-20
Completed
- A study to test different doses of BI 836880 combined with ezabenlimab in patients with advanced non-small cell lung cancer followed by other types of advanced solid tumours
- advanced solid tumours
- Yamagami Tomohiro
- 2020-11-18
Completed
- A study to find a safe and effective dose of BI 1701963 alone and in combination with BI 3011441 in patients with advanced cancer and a certain mutation (Kirsten rat sarcoma viral oncogene homologue [KRAS])
- KRAS mutation positive solid tumours (Parts A and B), KRAS mutation positive NSCLC and CRC (Parts C
- WU HAOYU
- 2021-03-01
Completed
- A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema
- Diabetic Macular Edema
- Clinical trials information
- 2021-01-20
Completed
- A study to evaluate the immunogenicity and safety of smallpox vaccine as vaccination to monkeypox in healthy adults
- Monkeypox
- Ujiie Mugen
- 2022-06-30
Completed
- A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)
- Preclinical AD
- Gesine Respondek, M.D.
- 2022-11-28
Completed
- A study to evaluate the effects of Biofermin tablets on bowel management in elderly patients requiring long-term care
- Constipation
- Maruyama Michio
- 2021-08-30
Completed
- A Study to Evaluate Efficacy of DDX-01 which Supports Screening for Diabetic Retinopathy and Diabetic Macular Edema
- Diabetis
- Tomita Koji
- 2022-10-04
Completed
- A study on the reactogenicity, safety and immune response of a targeted immunotherapy against HSV in healthy Japanese participants aged 18-40 years
- genital herpes
- Okawa Yasutoshi
- 2023-07-14